GWAS on family history of Alzheimer’s disease
暂无分享,去创建一个
R. Marioni | P. Visscher | N. Wray | A. McRae | I. Deary | D. Porteous | K. Evans | A. Goate | J. Starr | S. Harris | G. Davies | Jian Yang | S. Hagenaars | Qian Zhang | W. Hill | C. Ritchie | C. Gale | S. Harris | G. Davies | K. Evans
[1] Ace Inhibitors: Central Actions , 1994 .
[2] S. Johnston,et al. Alzheimer disease risk and genetic variation in ACE , 2004, Neurology.
[3] A. Hofman,et al. ACE gene is associated with Alzheimer's disease and atrophy of hippocampus and amygdala , 2005, Neurobiology of Aging.
[4] K. Sleegers,et al. Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease. , 2005, American journal of epidemiology.
[5] S. Hunt,et al. Common VKORC1 and GGCX polymorphisms associated with warfarin dose , 2005, The Pharmacogenomics Journal.
[6] Nicole Soranzo,et al. A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose , 2009, PLoS genetics.
[7] K. Elliott,et al. Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity. , 2009, Human molecular genetics.
[8] Yun Li,et al. METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..
[9] D. Altshuler,et al. A map of human genome variation from population-scale sequencing , 2010, Nature.
[10] P. Visscher,et al. Common SNPs explain a large proportion of heritability for human height , 2011 .
[11] L. Mucke,et al. Alzheimer Mechanisms and Therapeutic Strategies , 2012, Cell.
[12] Nick C Fox,et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.
[13] W. M. van der Flier,et al. The association of angiotensin-converting enzyme with biomarkers for Alzheimer’s disease , 2014, Alzheimer's Research & Therapy.
[14] R. Tanzi,et al. ADAM10 Missense Mutations Potentiate β-Amyloid Accumulation by Impairing Prodomain Chaperone Function , 2013, Neuron.
[15] Perry G. Ridge,et al. Genome-Wide Association Study of CSF Levels of 59 Alzheimer's Disease Candidate Proteins: Significant Associations with Proteins Involved in Amyloid Processing and Inflammation , 2014, PLoS genetics.
[16] Convergent genetic and expression data implicate immunity in Alzheimer's disease , 2015, Alzheimer's & Dementia.
[17] M. Daly,et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.
[18] M. Daly,et al. An Atlas of Genetic Correlations across Human Diseases and Traits , 2015, Nature Genetics.
[19] P. Elliott,et al. UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.
[20] Mitchell J. Machiela,et al. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants , 2015, Bioinform..
[21] L. Wain,et al. Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank , 2015, The Lancet. Respiratory medicine.
[22] Joris M. Mooij,et al. MAGMA: Generalized Gene-Set Analysis of GWAS Data , 2015, PLoS Comput. Biol..
[23] Christine Van Broeckhoven,et al. The genetic landscape of Alzheimer disease: clinical implications and perspectives , 2015, Genetics in Medicine.
[24] P. Visscher,et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets , 2016, Nature Genetics.
[25] Magda Tsolaki,et al. A NOVEL ALZHEIMER DISEASE LOCUS LOCATED NEAR THE GENE ENCODING TAU PROTEIN , 2015, Molecular Psychiatry.
[26] O. Andreassen,et al. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases , 2016, Journal of Neurology, Neurosurgery & Psychiatry.
[27] Daniel R Weinberger,et al. Mapping DNA methylation across development, genotype, and schizophrenia in the human frontal cortex , 2015, Nature Neuroscience.
[28] I. Deary,et al. Dementia ascertainment using existing data in UK longitudinal and cohort studies: a systematic review of methodology , 2017, BMC Psychiatry.
[29] Robert M. Maier,et al. Causal associations between risk factors and common diseases inferred from GWAS summary data , 2017, Nature Communications.
[30] H. Schmidt,et al. Genetics of vascular dementia – review from the ICVD working group , 2017, BMC Medicine.
[31] Erdogan Taskesen,et al. Functional mapping and annotation of genetic associations with FUMA , 2017, Nature Communications.
[32] L. Tan,et al. The Role of ADAM10 in Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.
[33] Yaniv Erlich,et al. Case–control association mapping by proxy using family history of disease , 2017, Nature Genetics.
[34] P. Donnelly,et al. Genome-wide genetic data on ~500,000 UK Biobank participants , 2017, bioRxiv.
[35] Luke R. Lloyd-Jones,et al. Transformation of Summary Statistics from Linear Mixed Model Association on All-or-None Traits to Odds Ratio , 2018, Genetics.
[36] Mitchell J. Machiela,et al. LDassoc: an online tool for interactively exploring genome-wide association study results and prioritizing variants for functional investigation , 2018, Bioinform..